期刊档案 · HEALTH CARE SCIENCES & SERVICES

Palliative Medicine Reports

ISSN 2689-2820 · Mary Ann Liebert · United States

Palliative Medicine Reports 中科院 医学 4区(2025 年升级版),影响因子 1.3(官网公布),完全开放获取,APC 约 1,250 美元,投稿社区反馈审稿约 7 周,2025 年发文 72 篇,ESCI、Scopus 收录。

影响因子1.3期刊官网公布的最新值
中科院分区医学 4区2025 年升级版大类 · 2026 新锐版 医学 4区
审稿周期约 7 周投稿社区平均反馈
版面费1,250 USD完全开放获取
录用比例—暂无反馈
年发文量72 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

Palliative Medicine Reports 由 Mary Ann Liebert 出版,属中科院医学大类(2025 升级版4区)。按 OpenAlex 近年发文统计,该刊主要发表 Palliative Care and End-of-Life Issues、Cancer survivorship and care、Grief, Bereavement, and Mental Health 等主题的论文,这 3 个主题约占 46.2%,主导子领域为 General Health Professions。(根据 OpenAlex 主题统计与中科院分区数据生成)

该刊近年发文主要集中在:Palliative Care and End-of-Life Issues(32.4%)、Cancer survivorship and care(7.2%)、Grief, Bereavement, and Mental Health(6.5%)、Pain Management and Opioid Use(6.2%)、Childhood Cancer Survivors' Quality of Life(6%)、Family and Patient Care in Intensive Care Units(5.1%)、Patient Dignity and Privacy(4.3%)、Patient-Provider Communication in Healthcare(3.8%);所属学科:Medicine、Health Professions、Psychology;来源标注的研究方向:HEALTH CARE SCIENCES & SERVICES-。(领域画像由 OpenAlex 发文统计生成,占比为近似值,非期刊官方描述)

由 OpenAlex 主题分布与研究方向自动生成的领域画像,非期刊官方表述。

研究方向(LetPub):HEALTH CARE SCIENCES & SERVICES

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. Palliative Care and End-of-Life IssuesMedicine32.4%
  2. Cancer survivorship and careMedicine7.2%
  3. Grief, Bereavement, and Mental HealthPsychology6.5%
  4. Pain Management and Opioid UseMedicine6.2%
  5. Childhood Cancer Survivors' Quality of LifeMedicine6%
  6. Family and Patient Care in Intensive Care UnitsHealth Professions5.1%
  7. Patient Dignity and PrivacyMedicine4.3%
  8. Patient-Provider Communication in HealthcareHealth Professions3.8%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)医学 4 区
类别学科分区
大类医学4 区
小类卫生保健与服务HEALTH CARE SCIENCES & SERVICES4 区

Top 期刊:否综述期刊:否

《新锐期刊分区表》( 2026年3月发布)医学 4 区
类别学科分区
大类医学4 区
小类卫生保健与服务HEALTH CARE SCIENCES & SERVICES4 区

Top 期刊:否综述期刊:未标注

期刊分区表( 2023年12月旧的升级版)未收录

该期刊未被此版本分区表收录。

数据库收录

ESCIScopusDOAJLetPub

国际期刊预警名单:各版本均未列入LetPub

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

影响因子(出版商公布)
1.3出版商官网 ·
五年影响因子(出版商公布)
1.7出版商官网 ·
CiteScore 2026-06
1.8LetPub ·
SJR 2026-06
0.5LetPub ·
SNIP 2026-06
0.63LetPub ·
h-index
19OpenAlex ·
i10-index
58OpenAlex ·
两年平均被引
1.16OpenAlex ·
自引率
7.7%LetPub ·
Gold OA 文章占比
100%LetPub ·

发文规模

年文章数
68LetPub ·

逐年发文量 OpenAlex 统计 · 累计 422 篇 · 当年数据不完整

年份发文量其中 OA被引
202666662
2025727266
20247878182
20235050189
20224848269
20215252436

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

平均审稿速度(社区反馈)
7 WeeksLetPub ·
投稿到发表(期刊自报)
约 7 周DOAJ ·
评审方式
双盲同行评审DOAJ

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

完全开放获取DOAJ

所有文章开放获取,通常向作者收取文章处理费(APC)。

来源文章处理费费用减免许可证观测时间
DOAJUSD 1,250无CC BY、CC BY-NC
OpenAlexUSD 1,250——
LetPubUSD 1,250无—
出版商官网USD 2,500——

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

投稿准备要点1 项,摘自作者指南
参考文献格式
Vancouver 格式
出版商官网 · 模型提取,逐项与原文核对
接收的文章类型19 种,含篇幅限制
  1. brief communicationManuscript Types and Guidelines Original Articles · 3,000-word limit · Structured abstract of no more than 250 words Review Articles 5,000-word limit. The revie…未说明篇幅
  2. brief communicationsBrief Communications · 500-word limit · May include one figure OR table · Maximum of four (4) references正文 ≤ 500 词
  3. brief reportManuscript Types and Guidelines Original Articles · 3,000-word limit · Structured abstract of no more than 250 words Review Articles 5,000-word limit. The revie…正文 ≤ 1,500 词
  4. case discussionsCase Discussions · 2,000-word limit · Maximum of three (3) figures · Maximum of two (2) tables · Maximum of 20 references正文 ≤ 2,000 词
  5. editorialManuscript Types and Guidelines Original Articles · 3,000-word limit · Structured abstract of no more than 250 words Review Articles 5,000-word limit. The revie…未说明篇幅
  6. editorials/special reportEditorials/Special Report · 1,000-word limit正文 ≤ 1,000 词
  7. letterManuscript Types and Guidelines Original Articles · 3,000-word limit · Structured abstract of no more than 250 words Review Articles 5,000-word limit. The revie…未说明篇幅
  8. letters to the editorManuscript Types and Guidelines Original Articles · 3,000-word limit · Structured abstract of no more than 250 words Review Articles 5,000-word limit. The revie…正文 ≤ 500 词
  9. meta-analysisManuscript Types and Guidelines Original Articles · 3,000-word limit · Structured abstract of no more than 250 words Review Articles 5,000-word limit. The revie…未说明篇幅
  10. narrative reviewManuscript Types and Guidelines Original Articles · 3,000-word limit · Structured abstract of no more than 250 words Review Articles 5,000-word limit. The revie…未说明篇幅
  11. original articleManuscript Types and Guidelines Original Articles · 3,000-word limit · Structured abstract of no more than 250 words Review Articles 5,000-word limit. The revie…未说明篇幅
  12. original articlesOriginal Articles · 3,000-word limit · Structured abstract of no more than 250 words正文 ≤ 3,000 词
  13. protocolManuscript Types and Guidelines Original Articles · 3,000-word limit · Structured abstract of no more than 250 words Review Articles 5,000-word limit. The revie…未说明篇幅
  14. qi (quality improvement) projectsQI (Quality Improvement) Projects · 3,000-word limit · Structured abstract of no more than 250 words正文 ≤ 3,000 词
  15. reviewManuscript Types and Guidelines Original Articles · 3,000-word limit · Structured abstract of no more than 250 words Review Articles 5,000-word limit. The revie…未说明篇幅
  16. review articleManuscript Types and Guidelines Original Articles · 3,000-word limit · Structured abstract of no more than 250 words Review Articles 5,000-word limit. The revie…未说明篇幅
  17. review articlesReview Articles 5,000-word limit.正文 ≤ 5,000 词
  18. study protocolsStudy Protocols · 3,000-word limit · Structured abstract of no more than 250 words正文 ≤ 3,000 词
  19. systematic reviewManuscript Types and Guidelines Original Articles · 3,000-word limit · Structured abstract of no more than 250 words Review Articles 5,000-word limit. The revie…未说明篇幅
出版商官网
官网政策摘录作者资格、数据可用性、出版伦理、开放获取、同行评审、查重、预印本、试验注册 / 报告规范
作者资格 Author contributions

该期刊采用CRediT(贡献者角色分类法,包含14种角色)来描述每位作者对工作的具体贡献,投稿时需列出每位作者的贡献,并在提交中于致谢部分之后加入“作者贡献”标题。 模型中文摘要

As part of our commitment to ensuring an ethical, transparent and fair peer review and publication process, this journal has adopted CRediT (Contributor Roles Taxonomy). CRediT is a high-level taxonomy, including 14 roles, which is used to describe each author’s individual contributions to the work. You will be asked to list the contribution of each author as part of the submission process. Please…

原文 ↗出版商官网 ·
数据可用性 Data availability

该期刊致力于促进研究的开放、透明和可重复性,在符合伦理和法律要求的前提下,鼓励作者在相关公共数据存储库共享研究数据、提供链接数据的可用性声明(无法共享时说明原因)并在研究中引用该数据。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

原文 ↗出版商官网 ·
出版伦理 Ethical considerations

作者须在该标题下提供伦理批准声明(即使方法部分已包含),若无需伦理批准也须明确说明;报告涉及人类参与者、人类数据或人类组织的研究时,须声明相关伦理委员会或机构审查委员会批准或豁免批准,并提供委员会全名、所属机构及批准号。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

原文 ↗出版商官网 ·
开放获取 Publishing fees and open access

Palliative Medicine Reports为开放获取同行评审期刊,接受的文章在出版后立即免费在线发布,采用知识共享许可并永久在线保存;同行评审接受后须支付一次性文章处理费(APC)2500美元,由资助方、机构或作者承担,提交稿件本身不收费。 模型中文摘要

Palliative Medicine Reports is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publishing, paid by t…

原文 ↗出版商官网 ·
同行评审 Peer review policy

该期刊实行双匿名同行评审,审稿人与编辑互动,不公布审稿信息;稿件先经初步评估,不符合要求将被退回修改,超出范围或不合适的稿件可能未经同行评审即被拒稿,通过初评后进入同行评审。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency: Double-anoynmizedReviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk reject…

原文 ↗出版商官网 ·
查重 Plagiarism

该期刊和Sage严肃对待版权侵犯、抄袭及其他违反出版最佳实践的行为,作者应阅读Sage完整的抄袭政策及可能采取的措施。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

原文 ↗出版商官网 ·
预印本 Preprints

该期刊接受已在预印本服务器发布的稿件,投稿时须在指定字段填写预印本DOI,并建议在投稿时告知编辑部;同行评审期间不应在预印本服务器发布更新版本。 模型中文摘要

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

原文 ↗出版商官网 ·
试验注册 / 报告规范 Clinical trial registration

该期刊遵循ICMJE要求,临床试验须在首次招募参与者之前或当时在WHO认可的公共试验注册库注册,作为发表考虑的条件,且试验注册库名称、URL和注册号须包含在摘要末尾。 模型中文摘要

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
Mary Ann Liebert
出版国家或地区
United States
出版语言
English
ISSN
2689-2820
官方链接

常见问题

关于 Palliative Medicine Reports 的常见问题

Palliative Medicine Reports 是中科院几区期刊?

2025 年升级版分区表中,Palliative Medicine Reports 为医学 4区,小类 卫生保健与服务 4 区。2026 年新锐版分区表中为医学 4区。不同版本与大小类分区不能混用。

Palliative Medicine Reports 的影响因子是多少?

期刊官网公布的影响因子为 1.3,属期刊自述数据,LetPub 暂无该刊的影响因子记录,CiteScore 为 1.8,h-index 为 19。

Palliative Medicine Reports 的审稿周期多长?

投稿社区反馈的平均审稿速度为约 7 周。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

Palliative Medicine Reports 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,Palliative Medicine Reports 被 ESCI、Scopus、DOAJ 收录。

Palliative Medicine Reports 是开放获取期刊吗?版面费多少?

Palliative Medicine Reports 为完全开放获取。APC 约 1,250 美元。

来源与更新

本页事实来自 LetPub、OpenAlex、DOAJ、出版商官网;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-26 归档)。最近更新:。